ResearchIn-Press PreviewDermatologyOncologyTherapeutics
Open Access |
10.1172/jci.insight.190287
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Fisher, R. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Park, K. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Lee, K. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Pinjusic, K. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Vanasse, A. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Ennis, C. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Farokh, P. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Ficarro, S. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Marto, J. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Jiang, H. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Nam, E. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Stransky, S. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Duke-Cohan, J. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Akinci, M. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Geethadevi, A. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Raabe, E. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Fiszbein, A. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by
Demehri, S.
in:
PubMed
|
Google Scholar
|
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Sidoli, S. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Hicks, C. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by
Keskin, D.
in:
PubMed
|
Google Scholar
|
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Wu, C. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Cole, P. in: PubMed | Google Scholar
1Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Division of Genetics, Departments of Medicine and Biological Chemistry and , Harvard Medical School and Brigham and Women’s Hospital, Boston, United States of America
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States of America
4Cancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
5Center for Cancer Immunology, Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America
6Department of Cancer Biology, Center for Emergent Drug Targets, and Blais P, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States of America
7Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States of America
8Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, United States of America
9Department of Biology, Boston University, Boston, United States of America
10Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
Find articles by Alani, R. in: PubMed | Google Scholar
Published December 9, 2025 - More info
Epigenetic macromolecular enzyme complexes tightly regulate gene expression at the chromatin level and have recently been found to colocalize with RNA splicing machinery during active transcription; however, the precise functional consequences of these interactions are uncertain. Here, we identify unique interactions of the CoREST repressor complex (LSD1-HDAC1-CoREST) with components of the RNA splicing machinery and their functional consequences in tumorigenesis. Using mass spectrometry, in vivo binding assays, and cryo-EM we find that CoREST complex-splicing factor interactions are direct and perturbed by the CoREST complex selective inhibitor, corin, leading to extensive changes in RNA splicing in melanoma and other malignancies. Moreover, these corin-induced splicing changes are shown to promote global effects on oncogenic and survival-associated splice variants leading to a tumor-suppressive phenotype. Using machine learning models, MHC IP-MS, and ELISpot assays we identify thousands of neopeptides derived from unannotated splice sites which generate corin-induced splice-neoantigens that are demonstrated to be immunogenic in vitro. Corin is further shown to reactivate the response to immune checkpoint blockade, effectively sensitizing tumors to anti-PD1 immunotherapy. These data position CoREST complex inhibition as a unique therapeutic opportunity which perturbs oncogenic splicing programs while also creating tumor-associated neoantigens that enhance the immunogenicity of current therapeutics.